These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20110820)

  • 1. Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest.
    El-Shabrawi MH; Mohsen NA; Sherif MM; El-Karaksy HM; Abou-Yosef H; El-Sayed HM; Riad H; Bahaa N; Isa M; El-Hennawy A
    Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):946-51. PubMed ID: 20110820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of biochemical markers for the prediction of liver fibrosis and necroinflammatory activity in hemodialysis patients with chronic hepatitis C.
    Canbakan M; Senturk H; Canbakan B; Toptas T; Tabak O; Ozaras R; Tabak F; Balcı H; Sut N; Ozbay G
    Nephron Clin Pract; 2011; 117(3):c289-95. PubMed ID: 20847572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of FibroTest-ActiTest with histopathology in demonstrating fibrosis and necroinflammatory activity in chronic hepatitis B and C.
    Uyar C; Akcam FZ; Ciris M; Kaya O; Kockar C; Isler M
    Indian J Pathol Microbiol; 2010; 53(3):470-5. PubMed ID: 20699505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of FibroTest-ActiTest in children with chronic hepatitis C virus infection.
    Hermeziu B; Messous D; Fabre M; Munteanu M; Baussan C; Bernard O; Poynard T; Jacquemin E
    Gastroenterol Clin Biol; 2010 Jan; 34(1):16-22. PubMed ID: 19726147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.
    Poynard T; Zoulim F; Ratziu V; Degos F; Imbert-Bismut F; Deny P; Landais P; El Hasnaoui A; Slama A; Blin P; Thibault V; Parvaz P; Munteanu M; Trepo C
    Am J Gastroenterol; 2005 Sep; 100(9):1970-80. PubMed ID: 16128941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the non-invasive serum marker FibroTest-ActiTest in the prediction of histological stage of fibrosis and activity in children with naïve chronic hepatitis B infection.
    Sökücü S; Gökçe S; Güllüoğlu M; Aydoğan A; Celtik C; Durmaz O
    Scand J Infect Dis; 2010 Sep; 42(9):699-703. PubMed ID: 20429710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of liver stiffness, fibrotest and liver biopsy for assessment of liver fibrosis in kidney-transplant patients with chronic viral hepatitis.
    Alric L; Kamar N; Bonnet D; Danjoux M; Abravanel F; Lauwers-Cances V; Rostaing L
    Transpl Int; 2009 May; 22(5):568-73. PubMed ID: 19196449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
    Sebastiani G; Vario A; Guido M; Alberti A
    J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C.
    Said Y; Salem M; Mouelhi L; Mekki H; Houissa F; Ben Rejeb M; Moussa A; Trabelsi S; Debbeche R; Bouzaidi S; Najjar T
    Tunis Med; 2010 Aug; 88(8):573-8. PubMed ID: 20711964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
    Maor Y; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
    Haemophilia; 2006 Jul; 12(4):372-9. PubMed ID: 16834736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis C.
    Fontanges T; Bailly F; Trepo E; Chevallier M; Maynard-Muet M; Nalet B; Beorchia S; Pillon D; Moindrot H; Froissart B; Slaoui M; Tinel X; Pradat P; Trepo C
    Gastroenterol Clin Biol; 2008 Oct; 32(10):858-65. PubMed ID: 18775614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus.
    Poynard T; Ngo Y; Marcellin P; Hadziyannis S; Ratziu V; Benhamou Y;
    J Viral Hepat; 2009 Mar; 16(3):203-13. PubMed ID: 19175871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
    Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
    Cross TJ; Calvaruso V; Maimone S; Carey I; Chang TP; Pleguezuelo M; Manousou P; Quaglia A; Grillo F; Dhillon AP; Dusheiko GM; Burroughs AK; Harrison PM
    J Viral Hepat; 2010 Aug; 17(8):546-54. PubMed ID: 19874477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy.
    Anastasiou J; Alisa A; Virtue S; Portmann B; Murray-Lyon I; Williams R
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):474-80. PubMed ID: 19887952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers.
    Sánchez-Conde M; Montes-Ramírez ML; Miralles P; Alvarez JM; Bellón JM; Ramírez M; Arribas JR; Gutiérrez I; López JC; Cosín J; Alvarez E; González J; Berenguer J
    J Viral Hepat; 2010 Apr; 17(4):280-6. PubMed ID: 19732322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.